These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25518215)

  • 21. [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
    Schofer J
    Dtsch Med Wochenschr; 1988 Oct; 113(43):1684-9. PubMed ID: 2846252
    [No Abstract]   [Full Text] [Related]  

  • 22. Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
    Hubers SA; Brown NJ
    Circulation; 2016 Jul; 134(3):e11-2. PubMed ID: 27436883
    [No Abstract]   [Full Text] [Related]  

  • 23. The NETWORK investigators.
    McDonald K; Maurer B
    Eur Heart J; 1998 Nov; 19(11):1740-1. PubMed ID: 9857930
    [No Abstract]   [Full Text] [Related]  

  • 24. [Omapatrilat for treatment of heart failure].
    Yamazaki T
    Nihon Rinsho; 2007 May; 65 Suppl 5():173-5. PubMed ID: 17571381
    [No Abstract]   [Full Text] [Related]  

  • 25. The ultimate follow-up.
    Coats AJ
    Eur Heart J; 1999 Jan; 20(2):85-6. PubMed ID: 10099901
    [No Abstract]   [Full Text] [Related]  

  • 26. NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial.
    Lainchbury JG; Troughton RW; Frampton CM; Yandle TG; Hamid A; Nicholls MG; Richards AM
    Eur J Heart Fail; 2006 Aug; 8(5):532-8. PubMed ID: 16829189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter by Singh regarding article, "Enalapril in infants with single ventricle: results of a multicenter randomized trial".
    Singh TP
    Circulation; 2011 Mar; 123(10):e374. PubMed ID: 21403120
    [No Abstract]   [Full Text] [Related]  

  • 31. Of fads, fashion, surrogate endpoints and dual RAS blockade.
    Messerli FH; Staessen JA; Zannad F
    Eur Heart J; 2010 Sep; 31(18):2205-8. PubMed ID: 20685681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials update from the European Society of Cardiology Meeting 2005: CIBIS-III. Response to correspondence from R. Willenheimer et al.
    Dickstein K
    Eur J Heart Fail; 2006 Mar; 8(2):221-2. PubMed ID: 16488369
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on "Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS-III, by JGF Cleland and others".
    Willenheimer R; Krum H; van Veldhuisen DJ; Funck-Brentano C; Erdmann E; Meyer WR;
    Eur J Heart Fail; 2006 Mar; 8(2):219-20. PubMed ID: 16488368
    [No Abstract]   [Full Text] [Related]  

  • 34. Striking the Right Balance in Heart Failure.
    Shah MR; Lauer MS
    Ann Intern Med; 2016 Jan; 164(2):125-6. PubMed ID: 26720859
    [No Abstract]   [Full Text] [Related]  

  • 35. How many medicines do patients with heart failure need?
    Parmley WW
    Circulation; 2001 Mar; 103(12):1611-2. PubMed ID: 11273985
    [No Abstract]   [Full Text] [Related]  

  • 36. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII].
    Dessì-Fulgheri P; Paci MV; Rappelli A
    Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letters to the editors.
    Angerstein RL; Lemberg L; Keller KB
    Am J Crit Care; 2005 Nov; 14(6):468; author reply 468-9. PubMed ID: 16249574
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 39. [Angiotensin-converting enzyme inhibitors in heart failure].
    Gullestad L; Søyland E; Dolva LO; Kjekshus J
    Tidsskr Nor Laegeforen; 1987 Sep; 107(25):2112-6. PubMed ID: 2823410
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug treatment of heart failure in chronic kidney disease].
    Marx N
    Internist (Berl); 2020 Apr; 61(4):357-361. PubMed ID: 31690996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.